BioHealth News Archive

Ellume welcomes Congressman David Trone, Senator Ben Cardin, Senator Chris Van Hollen and National Institute of Standards and Technology (NIST) Manufacturing Extension Partnership Director Laurie Locascio

Ellume welcomes Congressman David Trone, Senator Ben Cardin, Senator Chris Van Hollen and National Institute of Standards and Technology (NIST) Manufacturing Extension Partnership Director Laurie Locascio

It was a pleasure to welcome Congressman David Trone, Senator Ben Cardin, Senator Chris Van Hollen and National Institute of Standards and Technology (NIST)…

Read More
DC Inno – How 3 women-led life sciences startups thrive with TEDCO

DC Inno – How 3 women-led life sciences startups thrive with TEDCO

Maryland is home to a number of STEM entrepreneurs with quality projects and the skills to succeed. What entrepreneurs often lack are the right…

Read More
CHIPS Act Authorizes Unprecedented Support for Tech Transfer

CHIPS Act Authorizes Unprecedented Support for Tech Transfer

The arc of the technology transfer profession can be tied to the Bayh-Dole Act of 1980 in the United States and similar enabling legislation…

Read More
Ellume COVID test plant in Frederick starting to add automation to manufacturing | Coronavirus | fredericknewspost.com

Ellume COVID test plant in Frederick starting to add automation to manufacturing | Coronavirus | fredericknewspost.com

Five months after the Australian-based biopharmaceutical company Ellume opened its first U.S. location in Frederick, the facility is scaling up its production of at-home…

Read More
Alexandria – 940 CLOPPER ROAD – GAITHERSBURG, MARYLAND – AVAILABLE 1Q23 – 8,867 RSF OF LABORATORY/OFFICE SPACE

Alexandria – 940 CLOPPER ROAD – GAITHERSBURG, MARYLAND – AVAILABLE 1Q23 – 8,867 RSF OF LABORATORY/OFFICE SPACE

TENANT AMENITIES • 8,867 RSF lab/office suite available 1Q23 • Dedicated suite entry • Energy efficient HVAC • Loading dock • Ample parking •…

Read More
BioBuzz: BioHealth Capital Region Forum Crab Trap Winners: Where Are They Now?

BioBuzz: BioHealth Capital Region Forum Crab Trap Winners: Where Are They Now?

The BioHealth Capital Region Forum and Investment Conference are right around the corner on September 20th and 21st, 2022, respectively. And that means great networking opportunities, engaging…

Read More
BARDA Director Gary L. Disbrow, Ph.D., Joins Rich Bendis on the BioTalk Podcast

BARDA Director Gary L. Disbrow, Ph.D., Joins Rich Bendis on the BioTalk Podcast

Gary L. Disbrow, Ph.D., Director of the Biomedical Advanced Research and Development Authority (BARDA), visits BioTalk to discuss his career, advancing research, development, and…

Read More
Jos Joore

Jos Joore

This interview is part of a series of conversations with the people working at Mimetas. The 'I' in Mimetas focuses on the personal side…

Read More
Johns Hopkins spinout Emocha Health closes $6.2M series A for video-based medication adherence

Johns Hopkins spinout Emocha Health closes $6.2M series A for video-based medication adherence

Emocha Health, a Johns Hopkins University spinout tackling medication adherence with an asynchronous video platform, has announced a $6.2 million series A round led by…

Read More
What does #USPVerified mean?

What does #USPVerified mean?

What does #USPVerified mean? It means that you can trust that what's on the label is what's in the bottle. The USP Verified Mark…

Read More
Immunomic Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ITI-3000 pDNA Vaccine for the Treatment of Merkel Cell Carcinoma Member Discounts – Maryland Tech Council

Immunomic Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ITI-3000 pDNA Vaccine for the Treatment of Merkel Cell Carcinoma Member Discounts – Maryland Tech Council

ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP (Lysosome Associated Membrane Protein)-mediated nucleic acid-based immunotherapy, today…

Read More
IPO market in a ‘wait-and-see period,’ EY Americas IPO leader says

IPO market in a ‘wait-and-see period,’ EY Americas IPO leader says

EY Americas IPO Leader Rachel Gerring joins Yahoo Finance Live to discuss the U.S. IPO market, navigating through recessionary fears, inflation, supply chain woes,…

Read More

U.S. Department of Commerce Announces Winners of American Rescue Plan $500 Million Good Jobs Challenge to Expand Employment Opportunities | U.S. Economic Development Administration

WASHINGTON – Today, U.S. Secretary of Commerce Gina Raimondo announced grant awards to 32 industry-led workforce training partnerships across the country as part of…

Read More
Johns Hopkins spinout Emocha Health closes $6.2M series A for video-based medication adherence | Fierce Healthcare

Johns Hopkins spinout Emocha Health closes $6.2M series A for video-based medication adherence | Fierce Healthcare

Emocha Health, a Johns Hopkins University spinout tackling medication adherence with an asynchronous video platform, has announced a $6.2 million series A round led by…

Read More
Emergent BioSolutions unveils 7th pandemic CDMO contract, this time for Humanigen’s late-stage antibody hopeful | Fierce Pharma

Emergent BioSolutions unveils 7th pandemic CDMO contract, this time for Humanigen’s late-stage antibody hopeful | Fierce Pharma

Manufacturing powerhouse Emergent BioSolutions unveiled its seventh COVID-19 CDMO tie-up Monday, this time to help crank out Humanigen’s late-stage antibody hopeful lenzilumab. Emergent will…

Read More